Artivion | CRY - Net Income


Artivion reported $2.42M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 1.76M 2.02M Dec/2025
Baxter International USD -1.13B 1.08B Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Boston Scientific USD 672M 83M Dec/2025
Edwards Lifesciences USD 91.2M 199.9M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Integra LifeSciences USD -1.7M 3.7M Dec/2025
J&J USD 5.12B 36M Dec/2025
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
ResMed USD 392.59M 44.06M Dec/2025
Stryker USD 849M 10M Dec/2025
Surmodics USD -5.32M 6.22M Jun/2025
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -714.33M 305.44M Dec/2025
Terumo JPY 32.65B 2.4B Dec/2025
Trinity Biotech USD -5.14M 11.82M Sep/2025